维普中文期刊产品整合服务
40篇 您的检索式:作者名="BALLENGER JC"
    题名 作者 年代 出处 被引量
1Recognizing the paticent with anxiety disorder显示文摘Ballenger JC 2000Int Clin Psychopharmacol2000,151,:1
2Remission rates in patient s wit h anxiety disorders treated with paroxetine 显示文摘Ballenger JC 2004J Clin Psychiatry2004,65,12:1
3Generalized anxiety disorder: comorbidity, comparative biology and treatment显示文摘Nutt DJ Ballenger JC Sheehan D 2002The International Journal of Neuropsyehopharmaeology2002,5,:1
4Consensus on posttraumatic stress disorder fromthe international consensus group on depression and anxiety显示文摘Ballenger JC Davidson JRT 2000Clincial Psychiatry2000,61,5:1
5惊恐障碍的长期药物治疗显示文摘惊恐障碍的长期治疗可分为急性期、稳定期、维持期和停药期4个阶段。每个阶段均有其特殊的治疗目的。作者对每个治疗阶段可能出现的问题进行了讨论。现有的资料表明,长期药物治疗对恢复病人的整体功能是必要的。Ballenger JC 宋立升 1992国外医学(精神病学分册)1992,19,2:1
6Consensus statement on posttraumatic stress disorder from the International Consensus Group on Depression and Anxiety 显示文摘Ballenger JC Davidson JR Lecrubier Y 2000J Clin Psychiatry2000,615,:1
7Consensus statement on posttraumatic stress disorder from the International Consensus Group on Depression and Anxiety显示文摘Ballenger JC Davidson JR Lecrubier Y 2000J Clin Psychiatery2000,6,5:1
8A double-blind evaluation of the safety and efficacy of abecamil, alprazolam,and placebo in outpatients with generalized anxiety disorder 显示文摘Lydiard RB Ballenger JC R ickels K 1997J Clin Psychiatry1997,58,11:1
9Clinical guidelines for establishing remission in patients with depression and anxiety显示文摘Ballenger JC 1999J Clin Psychiatry1999,60,22:1
10Clinical guidelines for establishing remission in patients with depression and anxiety显示文摘Ballenger JC 1999Journal of Clinical Psychiatry1999,60,22:1
11Current treatment of the anxiety disorders in adults显示文摘Ballenger JC 1999Biol Psychiatry1999,46,11:1
12Efficacy and safety of olanzapine, clozapine and risperidone in treating schizophrenia 显示文摘WIRSHING DA BALLENGER JC FRENCKELL R 1998J Psychiatry1998,59,:1
13Doubleblind,fixed-dose,placebo-controlled study of paroxetine in the treatment of panic disorder显示文摘Ballenger JC Wheadon DE Steiner M 1998Am J Psychiatry1998,155,:1
14cerebrospinal fluid corticotropin-releasing factor concentrations in patients with anxiety disorder and normal comparison subjects显示文摘Fossey MD Lydiard RB Ballenger JC 1996Biol Psychiatry1996,39,:1
15Remission rates in patients with anxiety disorders treated with paroxetine显示文摘Ballenger JC 2004J Clin Psychiatry2004,65,12:1
16Recognizing the patient with anxiety disorder显示文摘Ballenger JC 2000Int Clin Psychopharmacol2000,,:1
17Consensus statement on posttraumatic stress disorder from the International Consensus Group on depression and anxiety 显示文摘Ballenger JC Davidson JR Lecrubier Y 2000J Clin Psychiatry2000,61,5:1
18Clinical guidelines for establishing remission in patients with depression and anxiety 显示文摘Ballenger JC 1999Journal of Clinical Psychiatry1999,60,22:1
19Consensus statement on posttrumatic stress disorder from the International Consensus Group on dep ression and anxiety 显示文摘Ballenger JC 2000J Clin Psychiatry2000,61,5:1
20A proposed algorithm for improved recognition and treatment of the depression/anxiety spectrum in primary care显示文摘Ballenger JC Davidson JR Lecrubier Y 2001Prim Care Companion J Clin Psychiatry2001,3,2:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费